Ibogaine Safety: What a Support Person Needs to Know

Most writing about ibogaine safety is addressed to the patient. That makes sense, but it leaves out the person who is often doing the practical work: the spouse, parent, sibling, or friend who books the flights, sits in the waiting area, and drives home afterward. A support person is not a substitute for medical staff, and nothing in this guide should be read that way. But there are things a companion can see, ask, and do that genuinely change how safe the experience is, before the trip, during the session, and in the fragile weeks after.

This guide is for that companion. It assumes you have read the basics on our ibogaine safety protocols page, which covers the cardiac risk, the screening tests, and the monitoring a clinic should provide. Here we focus on your role: what to understand before departure, how to be useful without getting in the way, which warning signs to watch for, and the one risk after discharge that families most often underestimate.

Why Does Ibogaine Safety Involve a Support Person at All?

Ibogaine is unusual among treatments in how much it asks of the patient physically. The session can last the better part of a day, and the medicine's effects on balance, heart rhythm, and sleep continue well after the visionary phase ends. Patients are frequently unable to walk unassisted for many hours, may be nauseated, and are often exhausted and emotionally raw for days. Clinics provide the medical monitoring, but the person who knows the patient best is often the first to notice that something is off.

There is also a more uncomfortable reason. Patients going through screening sometimes minimize their use, forget a medication, or leave out a hospitalization because they are afraid of being turned away. A support person who knows the real history can gently make sure the clinic hears it. The physician's safety plan is built on the history they are given, and a companion who helps make that history complete is doing real safety work.

Finally, discharge is not the end of the risk window. The days and weeks after treatment carry their own hazards, and that is when a support person is often the only person present.

What Should a Support Person Know Before Departure?

Start with the medicine itself. If you have not already, read what is ibogaine so you understand why the heart is the central concern, why the session lasts so long, and why the clinic asks so many questions about medications. You do not need a medical background. You need enough context to recognize when something the clinic says does not match what you have read.

Then learn the patient's own screening results. Ask to see, or ask the patient to share, the ECG findings, the blood work, and the physician's written clearance. If a clinic treats without an ECG, without electrolyte testing, or without a physician reviewing the medication list, that is a reason to stop, not a detail to work around.

Understand the pre-treatment taper plan. Many patients must switch from long-acting opioids like methadone or buprenorphine to a short-acting opioid before treatment, must taper benzodiazepines slowly, and must stop certain antidepressants and other QT-prolonging medications over a supervised timeline. A support person can help keep that timeline honest. Sudden changes made in secret, in either direction, are among the most dangerous things a patient can do in the final days before a session.

Pack practically. Bring the patient's complete medication list, identification and insurance documents, the contact details of their home physicians, and your own written notes on the plan. Make sure you know where the nearest hospital with emergency cardiac care is relative to the clinic, and how a patient would get there if needed. Ask the clinic this directly; the answer tells you a lot.

What Does the Support Person Do During the Session?

During the dose itself, the most useful thing you can do is let the medical team work. Continuous cardiac monitoring, blood pressure checks, pulse oximetry, and intravenous access are their domain. Your role is quieter, and it still matters.

Be the historian. If staff ask when the patient last used, what dose, or whether they have ever had a seizure, you may be able to answer when the patient cannot. Keep your own notes on the timeline: when dosing started, when nausea appeared, what staff said and when. If anything later needs to be reconstructed, those notes are the record.

Respect the patient's experience. The visionary phase is often described as a review of one's own life, and it is deeply private. Patients usually do not want conversation, touch, or reassurance during it, and many clinics limit companion access to the treatment room for exactly that reason. Being nearby and available is enough.

Watch for the moments when a patient tries to get up. Ataxia, the loss of coordination that ibogaine causes, is one of the most common sources of injury: a patient who feels fine and tries to walk to the bathroom alone can fall hard. If the clinic's staffing is thin, a companion stationed nearby, under staff direction, can reduce that risk.

Finally, notice how the clinic responds when you ask questions. A safe program will explain what the monitor shows, what the plan is if the QT interval climbs, and who is physically present overnight. Evasiveness is itself a safety signal, and you are allowed to act on it.

What Are the Warning Signs After Discharge?

Once the patient is cleared to leave, the burden of observation shifts to you. The site's ibogaine guide covers the broader recovery arc; here are the specific physical and psychological signs that warrant a call to the clinic or, if severe, to emergency services.

Cardiac and physical signs

• Fainting, near-fainting, or a racing or irregular heartbeat, especially in the first several days.
• Chest discomfort, shortness of breath, or unusual swelling.
• Persistent vomiting or diarrhea, which can disturb electrolytes and raise cardiac risk.
• Confusion, severe tremor, or coordination that is getting worse rather than steadily better.

Psychological signs

• Prolonged inability to sleep beyond what the clinic described as expected.
• Expressions of hopelessness or suicidal thinking, which can surface as the emotional intensity of the session settles.
• Withdrawal from contact, sudden secrecy, or renewed contact with people associated with past use.

Keep the patient hydrated, fed, and away from alcohol and recreational substances. Ask the clinic for a written list of the medications the patient may and may not take during recovery, including common over-the-counter products, since some of those also affect heart rhythm. If you are in the United States and the person you are caring for is in crisis, call or text 988.

Why Is Lost Opioid Tolerance the Biggest Risk After Ibogaine?

This is the section most families need and least expect. When ibogaine interrupts opioid dependence, it also removes the tolerance the patient built up over months or years. A dose that was routine before treatment can be fatal afterward. The same lost-tolerance risk exists after any detox, but ibogaine's speed makes the drop more abrupt, and the emotional vulnerability of the post-treatment period can make a return to use more likely, not less.

What a support person can do:

• Make sure naloxone is in the house, that you know how to use it, and that others in the home do too.
• Help remove leftover substances and paraphernalia from the home before the patient returns, with the patient's agreement.
• Keep the first weeks structured: integration therapy, appointments, sleep, meals, movement. Isolation and boredom are not neutral.
• Agree in advance on what happens if the patient uses, so that a lapse leads to a phone call rather than a hidden second dose.

A return to use after ibogaine carries overdose risk from the very first dose, so treat any lapse as an urgent medical situation rather than a moral failure. Say that out loud before you travel, and mean it.

What Questions Should a Support Person Ask the Clinic?

Before committing, ask in writing and expect direct answers:

• Who reads the ECG, and what corrected QT threshold leads the physician to postpone or cancel?
• What continuous monitoring is used during and after the dose, and for how many hours?
• Is a physician physically present during the session and overnight, or only on call?
• What emergency equipment is on site, and what is the plan and distance to hospital cardiac care?
• How are long-acting opioids, benzodiazepines, and antidepressants handled before treatment?
• What discharge criteria must be met before the patient leaves, and what written aftercare instructions will you receive?
• Who can you call, day or night, in the first two weeks after discharge?

A clinic that welcomes these questions is showing you how it treats patients. A clinic that bristles at them is showing you something too.

Ibogaine safety is a shared project between a well-screened patient, a properly equipped medical team, and the people around them. A support person cannot replace the monitor or the physician, but they can make the history complete, catch the fall, notice the warning sign, and be ready for the lapse that must never become an overdose. Use the Ibogaine Treatment Guide to prepare before you travel, and bring your questions with you.